Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB for Post-Operative Lung Atelectasis in Bariatric Surgery
NCT06695858Phase 3Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine in atelectasis (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence/Severity of Lung Atelectasis at 6 hours. Started Nov 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
atelectasis
Beyond the preview
Go deeper on NCT06695858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06695858.